Moneycontrol
Oct 13, 2017 05:59 PM IST | Source: Moneycontrol.com

HCG Q2 PAT seen up 19.8% YoY to Rs. 5.9 cr: Kotak

Net Sales are expected to increase by 15.8 percent Y-o-Y (up 5.4 percent Q-o-Q) to Rs. 201.4 crore, according to Kotak.

HCG Q2 PAT seen up 19.8% YoY to Rs. 5.9 cr: Kotak

Kotak has come out with its second quarter (July-September) earnings estimates for the Pharmaceuticals sector. The brokerage house expects HCG to report net profit at Rs. 5.9 crore up 19.8% year-on-year (24.2% quarter-on-quarter).


Net Sales are expected to increase by 15.8 percent Y-o-Y (up 5.4 percent Q-o-Q) to Rs. 201.4 crore, according to Kotak.


Earnings before interest, tax, depreciation and amortization (EBITDA) are likely to rise by 22.3 percent Y-o-Y (up 5.3 percent Q-o-Q) to Rs. 31.1 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

X
Sections
Follow us on
Available On